A new application for liposomes in cancer therapy. Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugs. [electronic resource]
- FEBS letters Dec 1993
- 485-90 p. digital
Publication Type: Journal Article
0014-5793
10.1016/0014-5793(93)80861-n doi
Antibodies, Monoclonal Cell Division--drug effects Cell Line Drug Carriers Epirubicin--analogs & derivatives Female Glucuronates--metabolism Glucuronidase--metabolism Humans Immunoglobulin Fab Fragments Liposomes Ovarian Neoplasms Prodrugs--metabolism Tumor Cells, Cultured